Vertex Pharmaceuticals
VRTX
#175
Rank
A$175.81 B
Marketcap
A$685.73
Share price
-0.41%
Change (1 day)
-3.83%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total debt

Total debt on the balance sheet as of September 2025 : A$2.76 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total debt is A$2.76 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Vertex Pharmaceuticals - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31A$2.81 B137.05%
2023-12-31A$1.18 B-10.25%
2022-12-31A$1.32 B-0.92%
2021-12-31A$1.33 B10.1%
2020-12-31A$1.21 B28.24%
2019-12-31A$0.94 B13.45%
2018-12-31A$0.83 B7.24%
2017-12-31A$0.77 B-33.4%
2016-12-31A$1.16 B2.84%
2015-12-31A$1.13 B12.52%
2014-12-31A$1.00 B77.49%
2013-12-31A$0.56 B-15.31%
2012-12-31A$0.67 B50.81%
2011-12-31A$0.44 B-15.88%
2010-12-31A$0.52 B208.7%
2009-12-31A$0.17 B-57.98%
2008-12-31A$0.40 B1681.62%
2007-12-31A$22.87 M-85.43%
2006-12-31A$0.15 B-36.22%
2005-12-31A$0.24 B-43.14%
2004-12-31A$0.43 B-3.51%
2003-12-31A$0.44 B-22.97%
2002-12-31A$0.58 B-9.27%
2001-12-31A$0.64 B-0.95%
2000-12-31A$0.64 B5932.79%
1999-12-31A$10.74 M-32.88%
1998-12-31A$16 M24.14%
1997-12-31A$12.89 M20.5%
1996-12-31A$10.69 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Gilead Sciences
GILD
A$37.54 B 1,259.33%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$103.49 B 3,646.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$62.28 B 2,154.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$76.84 B 2,681.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$68.94 B 2,395.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A$87.39 M-96.84%๐Ÿ‡บ๐Ÿ‡ธ USA